Milan, Italy

Federica Colombo


 

Average Co-Inventor Count = 5.7

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Milan, IT (2017 - 2018)
  • Mariano Comense, IT (2019 - 2020)

Company Filing History:


Years Active: 2017-2020

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Federica Colombo: Innovator in Pharmaceutical Chemistry

Introduction

Federica Colombo is a prominent inventor based in Milan, Italy. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the synthesis of key intermediates for various drugs. With a total of six patents to her name, her work has had a substantial impact on drug development.

Latest Patents

Colombo's latest patents include a process for the preparation of indanamine derivatives and new synthesis intermediates. This invention focuses on creating key intermediates essential for the synthesis of indacaterol, a medication used in treating respiratory conditions. Additionally, she has developed a process for preparing intermediates useful in the synthesis of antifungal drugs, such as efinaconazole. This patent also encompasses novel synthesis intermediates and their applications in drug formulation.

Career Highlights

Throughout her career, Federica Colombo has worked with notable companies in the pharmaceutical industry, including Olon S.p.a. and Laboratorio Chimico Internazionale S.p.a. Her expertise in chemical processes and drug synthesis has positioned her as a valuable asset in these organizations.

Collaborations

Colombo has collaborated with esteemed colleagues, including Stefano Maiorana and Aldo Bianchi. These partnerships have fostered innovation and contributed to the advancement of pharmaceutical research.

Conclusion

Federica Colombo's contributions to pharmaceutical chemistry through her patents and collaborations highlight her role as a leading inventor in the field. Her work continues to influence drug development and synthesis processes, showcasing her dedication to innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…